Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16 - JSON Representation

Raw json | Download


{
  "resourceType" : "ArtifactAssessment",
  "id" : "179698",
  "meta" : {
    "versionId" : "4",
    "lastUpdated" : "2023-12-06T08:41:24.889Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ArtifactAssessment</b><a name=\"179698\"> </a><a name=\"hc179698\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceArtifactAssessment &quot;179698&quot; Version &quot;4&quot; Updated &quot;2023-12-06 08:41:24+0000&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-adaptation.html\">Adaptation</a></p></div><p><b>Artifact Author</b>: Joanne Dehnbostel: </p><p><b>Artifact URL</b>: <a href=\"https://fevir.net/resources/ArtifactAssessment/179698\">https://fevir.net/resources/ArtifactAssessment/179698</a></p><p><b>Artifact Description</b>: This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data.</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier/179698</p><p><b>title</b>: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16</p><p><b>artifact</b>: <a href=\"Composition-179466.html\">Composition/179466: Recommendation: ADA Obesity Management Recommendation 8.16</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: container</p><p><b>type</b>: adapted element <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>classifier</b>: string Datatype <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#string-datatype)</span></p><p><b>path</b>: <code>overallSummary</code></p><h3>Components</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td></tr><tr><td style=\"display: none\">*</td><td>comment</td><td>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A</td><td>Original Resource Content <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#OriginalResourceContent)</span></td><td> </td></tr><tr><td style=\"display: none\">*</td><td>response</td><td> </td><td>Rationale for Change to Resource Content <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#RationaleForChange)</span></td><td>Suggested change <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#suggested-change)</span></td></tr><tr><td style=\"display: none\">*</td><td>change-request</td><td>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.</td><td>Suggested Change to Resource Content <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#SuggestedChange)</span></td><td> </td></tr></table></blockquote></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Joanne Dehnbostel"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-url",
      "valueUri" : "https://fevir.net/resources/ArtifactAssessment/179698"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown" : "This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."
    }
  ],
  "modifierExtension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-status",
      "valueCode" : "active"
    }
  ],
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net",
      "value" : "179698",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "title" : "Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16",
  "artifactReference" : {
    🔗 "reference" : "Composition/179466",
    "type" : "Composition",
    "display" : "Recommendation: ADA Obesity Management Recommendation 8.16"
  },
  "content" : [
    {
      "informationType" : "container",
      "type" : {
        "text" : "adapted element"
      },
      "classifier" : [
        {
          "coding" : [
            {
              "system" : "https://fevir.net/resources/CodeSystem/179423",
              "code" : "string-datatype",
              "display" : "string Datatype"
            }
          ]
        }
      ],
      "path" : [
        "overallSummary"
      ],
      "component" : [
        {
          "informationType" : "comment",
          "summary" : "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A",
          "type" : {
            "coding" : [
              {
                "system" : "https://fevir.net/resources/CodeSystem/179423",
                "code" : "OriginalResourceContent",
                "display" : "Original Resource Content"
              }
            ]
          }
        },
        {
          "informationType" : "response",
          "type" : {
            "coding" : [
              {
                "system" : "https://fevir.net/resources/CodeSystem/179423",
                "code" : "RationaleForChange",
                "display" : "Rationale for Change to Resource Content"
              }
            ]
          },
          "classifier" : [
            {
              "coding" : [
                {
                  "system" : "https://fevir.net/resources/CodeSystem/179423",
                  "code" : "suggested-change",
                  "display" : "Suggested change"
                }
              ]
            }
          ]
        },
        {
          "informationType" : "change-request",
          "summary" : "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.",
          "type" : {
            "coding" : [
              {
                "system" : "https://fevir.net/resources/CodeSystem/179423",
                "code" : "SuggestedChange",
                "display" : "Suggested Change to Resource Content"
              }
            ]
          }
        }
      ]
    }
  ]
}